| Small Cell Neuroendocrine Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 145show all (up to 200) |
|---|
| → investigated in trials for | Etoposidesmall_molecule 135 trials (52 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 135 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 123 trials (46 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 123 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 84 trials (24 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall_molecule 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 57 trials (34 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 53 trials (36 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 40 trials (15 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 36 trials (7 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 25 trials (11 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 24 trials (7 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 22 trials (19 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 20 trials (15 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal_antibody 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Small Cell Neuroendocrine Carcinoma | 15 | Observed | clinicaltrials | graph → |